Open AccessPrognostic role of plasma level of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factor in hepatocellular carcinoma
Author(s) -
Gwang Hyeon Choi,
Eun Sun Jang,
Jin-Wook Kim,
SookHyang Jeong
Publication year - 2021
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v27.i27.4453
Subject(s) - angiopoietin 2 , hepatocellular carcinoma , angiogenesis , angiopoietin , vascular endothelial growth factor , medicine , liver cancer , stage (stratigraphy) , tumor progression , endocrinology , cancer , oncology , gastroenterology , biology , vegf receptors , paleontology
Most hepatocellular carcinomas (HCCs) are hypervascular, with characteristic features of hepatic arterial supply to the tumor. The factors involved in tumor angiogenesis include angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), and vascular endothelial growth factor (VEGF).